scholarly journals The Predictive Role of C-Reactive Protein on Sudden Death: A meta-analysis of prospective studies

Author(s):  
Ruhua Zhou ◽  
◽  
Jingjing Xu ◽  
Jiaochen Luan ◽  
Weiyun Wang ◽  
...  

This study was a diagnostic research, so the content was decomposed according to PIRO : P: Patients diagnosed with sudden death; I: C-reactive protein; R: There is no gold standard for sudden death, and the definition of sudden death varies from literature to literature. The World Health Organization defines sudden death: "Patients who are normally healthy or seemingly healthy die suddenly due to natural diseases in an unexpectedly short period of time." In our study, sudden death is determined by the history, symptoms, physical examination and electrocardiogram results assesed by doctor. If death events were collected from the patients’ medical records, deaths coded using the International Classification of Diseases-9th Revision, codes 410 to 414 for non-SCD and 798.1 for SCD; or the International Classification of Diseases-10th Revision, codes I20 to I25 for non-SCD and I46 for SCD. All deaths registered as sudden deaths were confirmed in interviews with the patient’s physician or family members again. O: sudden death.

2017 ◽  
Vol 27 (10) ◽  
pp. 1872-1938 ◽  
Author(s):  
Rodney C. G. Franklin ◽  
Marie J. Béland ◽  
Steven D. Colan ◽  
Henry L. Walters ◽  
Vera D. Aiello ◽  
...  

AbstractAn internationally approved and globally used classification scheme for the diagnosis of CHD has long been sought. The International Paediatric and Congenital Cardiac Code (IPCCC), which was produced and has been maintained by the International Society for Nomenclature of Paediatric and Congenital Heart Disease (the International Nomenclature Society), is used widely, but has spawned many “short list” versions that differ in content depending on the user. Thus, efforts to have a uniform identification of patients with CHD using a single up-to-date and coordinated nomenclature system continue to be thwarted, even if a common nomenclature has been used as a basis for composing various “short lists”. In an attempt to solve this problem, the International Nomenclature Society has linked its efforts with those of the World Health Organization to obtain a globally accepted nomenclature tree for CHD within the 11th iteration of the International Classification of Diseases (ICD-11). The International Nomenclature Society has submitted a hierarchical nomenclature tree for CHD to the World Health Organization that is expected to serve increasingly as the “short list” for all communities interested in coding for congenital cardiology. This article reviews the history of the International Classification of Diseases and of the IPCCC, and outlines the process used in developing the ICD-11 congenital cardiac disease diagnostic list and the definitions for each term on the list. An overview of the content of the congenital heart anomaly section of the Foundation Component of ICD-11, published herein in its entirety, is also included. Future plans for the International Nomenclature Society include linking again with the World Health Organization to tackle procedural nomenclature as it relates to cardiac malformations. By doing so, the Society will continue its role in standardising nomenclature for CHD across the globe, thereby promoting research and better outcomes for fetuses, children, and adults with congenital heart anomalies.


2019 ◽  
pp. 32-32
Author(s):  
Alessandra Diehl ◽  
Jair de Jesus Mari ◽  
Elias Abdalla Filho

The World Health Organization (WHO) has made substantial changes to the classification of paraphilic disorders (F65) for the Eleventh Revision of the International Classification of Diseases and Related Health Problems (ICD-11). Its expected that by January 2022 the ICD-11 may already be used by clinicians and stakeholders in many countries around the world.


2014 ◽  
Vol 155 (39) ◽  
pp. 1535-1537
Author(s):  
Balázs Babarczy

The development of the 11th revision of the International Classification of Diseases has been underway since 2007. The World Health Organisation, its coordinator, currently schedules the completion to 2017. The novel classification system has a similar high-level structure than the 10th revision of the International Classification of Diseases, while the entities are significantly more detailed and contain more parameters. The development process aims at the harmonisation of the 11th revision definitions with the codes of other information technology systems, potentially allowing the statistical use of far more clinical information than at present. Meanwhile, this complex development process is confronted at several difficulties. The developers are awaiting the comments of all professionals concerning the Beta-version of the system, available on the Internet. Orv. Hetil., 2014, 155(39), 1535–1537.


Sign in / Sign up

Export Citation Format

Share Document